Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies.

Following the success of PD1/PDL1 checkpoint inhibitors a new wave of ICI now enters the clinic, amongst which TIGIT has shown exciting preliminary results and sparked great excitement in this nascent field. With 27 ongoing clinical trials investigating TIGIT in front- and second-line indications, a great deal of momentum has built in this competitive space.

However, core challenges must still be addressed by the community, such as:

• Investigating the TIGIT pathway, ligands, and modes of action
• Optimizing biomarker strategy to identify optimal patient populations and indications
• Rationalizing combination strategy to leverage the TIGIT mechanise for maximum therapeutic benefit

The TIGIT Therapies Digital Summit will gather the greatest minds in TIGIT research in a dedicated, two day meeting. Gain access to 1:1 time with leaders in TIGIT research and take away tangible learnings for your future research.

In such a fast-paced industry, this is a unique opportunity to provide an overview of the ‘knowns and unknowns’ in the field and draw a path for best practice in the safe development of TIGIT therapies with maximum clinical impact.

Working with leaders in the industry we have developed a meeting that brings together the best and brightest minds within the development of TIGIT therapies to bring you the opportunity to share invaluable insights, leverage the collective experiences of years of expertise and network and collaborate with the movers and shakers; all with the ultimate aim of accelerating the clinical to commercial development of TIGIT therapies.

At a time when we are more isolated than ever, this event will break down barriers and provide the opportunity for frank and open discussion to ensure the continued progress and development of TIGIT therapies.

Head to the TIGIT Therapies Digital Summit website to access your complimentary event guide and find out more!